On January 11, 2021 DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage biopharmaceutical company developing novel treatments for neurological and kidney diseases, reported that it will be presenting at the H.C. Wainwright BioConnect 2021 Conference, being held virtually between January 11-14, 2021 (Press release, DiaMedica, JAN 11, 2021, https://ir.diamedica.com/news/detail/1609/diamedica-therapeutics-to-present-at-the-h-c-wainwright-bioconnect-conference [SID1234573794]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The recorded presentation will be available on the Investors section of the Company’s website at View Source beginning Monday, January 11th.